MedAI Verdict
Surgical AI

AI Surgical Tools

C-SATS

by J&J MedTech

Last verified

Surgical video review and analytics platform.

At a glance

Pricing
Enterprise.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
—
On this page

Independent score  ·  By our public rubric

24/100Niche fit
How it’s computed →
  • Regulatory & Compliance
    0/28

    No FDA clearance listed

  • Clinical Integration
    0/26

    No EHR integrations listed

  • Evidence Strength
    18.6/28.8

    3 peer-reviewed papers

  • Vendor & Market
    6/18

    Early-stage company

  • Sentiment & Transparency
    2.5/14

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/18

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/14

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/4

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers15/21

    3 peer-reviewed papers

  • RCT / meta-analysis / systematic review4/8

    1 observational study (no RCT)

Vendor & Market

  • Funding & adoption signal6/12

    Early-stage company

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/9

    No clinician sentiment data available

  • Pricing transparency3/5

    Pricing on request, no public amounts

Scored October 15, 2026 · Public scoring method v1.1.0

Bottom line

Surgical video review and analytics platform.

Free tier available.

Editorial review  ·  By MedAI Verdict

Bottom line

C-SATS is a surgical video review platform owned by Johnson & Johnson, built to assess how well surgeons operate by having experts and trained reviewers score recorded cases. It is a training and quality tool for surgical departments, not a clinical decision aid and not a scribe. Pricing is enterprise only and undisclosed. The peer-reviewed record is real but small: three papers mention it, alongside older validation work. It suits a surgical training program or hospital that already records minimally invasive cases and wants structured feedback. It does not suit a practice with no video recording workflow, because the platform has nothing to score without footage.

What is C-SATS and who sells it?

C-SATS' own site calls it "a post-operative surgical insights platform". The name stands for Crowd-Sourced Assessment of Technical Skills. J&J MedTech describes it as part of its Digital Solutions ecosystem, a SaaS-based, device-agnostic platform for surgical data management and learning (J&J MedTech and C-SATS sites).

The company began in Seattle in 2014 as a University of Washington spinout. Johnson & Johnson acquired it in April 2018 and did not disclose the price, and GeekWire reported that C-SATS had raised nearly $6M before the sale and had more than 20 employees (GeekWire, 2018, UW CoMotion). Today it is sold under J&J MedTech. J&J also operates the Polyphonic digital platform for surgical applications (MedTech Dive). Its relation to C-SATS is not stated in public sources. Whether C-SATS is still sold as a standalone product or folded into J&J's wider digital offering is also not confirmed.

What does C-SATS do?

The site describes a workflow in which video from minimally invasive procedures goes into a private cloud case library. Expert surgeons and trained reviewers assess the footage, and skills are benchmarked over time with validated rating tools. The crowd-sourced element is part of the method, which C-SATS explains on its validation page. Dashboards and AI-powered insights are offered on demand.

The site also describes a library of about 19,000 procedure videos, expert case series across more than 10 specialties, an Academy and Community area, and an iOS app (vendor figures).

The vendor's pitch to a program director is that human skill assessment is slow, and that a cloud library with structured ratings turns video that would otherwise sit unused into feedback.

What does C-SATS do well?

Its method has a documented scientific base. The vendor's validation page builds on Birkmeyer and colleagues' 2013 New England Journal of Medicine study, "Surgical skill and complication rates after bariatric surgery". That is the foundation for rating technical skill at all (cited by the vendor).

A second study, by White and colleagues in the Journal of Endourology in 2015, reported a 0.95 correlation between crowd and expert ratings on dry-lab robotic tasks. A 2022 systematic review in the Journal of Surgical Research reported 16 studies of the platform, of which 12 showed good or excellent correlation between crowd and expert ratings. Together they suggest the crowd rating method tracks expert judgement in many settings, particularly structured or simulated tasks.

J&J acquired the company in 2018, and a department evaluating a multi-year training tool can ask how long the vendor will support it, keeping in mind that its standalone status is not stated.

The vendor states HIPAA compliance and a HITRUST CSF-certified cloud case library on its site. The certificate was not seen, so a buyer should ask for the HITRUST letter.

Where does C-SATS fall short?

The evidence on training outcomes is limited. A 2025 paper in Surgical Endoscopy is titled "Evaluating the evaluators: does C-SATS measure up?" (PMID 40954374).

Adoption is a barrier in at least one real rollout. A 2024 mixed-methods study in Surgical Endoscopy examined the real-world implementation of a surgical video recording platform and reported barriers to routine recording (PMID 39148005). The platform is not named in the title. C-SATS needs video in order to produce any assessment.

A 2022 Cureus paper on cloud-based AI video analytics in laparoscopic surgery, framed in its title as a step toward a "virtual portfolio" (PMID 36259009), addresses a related use case: documenting a surgeon's cases and skill progression. By its title it is a concept paper, not an outcome trial.

No community threads about C-SATS are published, so there are no user reports to cite. No price, customer count, EHR integration list or FDA statement is published either.

How does C-SATS compare with Theator, Proximie and others?

Comparable products in surgical AI include Theator, Caresyntax, Proximie, Touch Surgery, OR Black Box, DeepOR, Activ Surgical, J&J Digital Surgery and Precision OS. An American College of Surgeons Bulletin overview from late 2023 surveys video-based technologies in the operating room as a category with potential to change healthcare.

No head-to-head comparison of these products is published. C-SATS is built around human assessment of recorded cases with validated tools, with AI insights layered on top, and its validation literature is specific to that task. If your priority is formal, repeatable skill rating for trainees, it is the one to evaluate first. For other uses, such as live operating room data or remote case support, look at the others.

What does the evidence say about C-SATS?

Three PubMed items mention the tool, all from surgical journals and none a randomised trial. One is "Evaluating the evaluators: does C-SATS measure up?" (Surgical Endoscopy, 2025, observational, PMID 40954374). Another is a mixed-methods study of barriers to routine surgical video recording in a real-world rollout (Surgical Endoscopy, 2024, PMID 39148005). The third is a paper on cloud-based AI video analytics in laparoscopic surgery as a virtual portfolio (Cureus, 2022, PMID 36259009).

The older work adds the 2013 NEJM study, the 2015 endourology correlation and the 2022 systematic review of 16 studies. Crowd ratings correlate with expert ratings in several settings, and surgical skill relates to complication rates after bariatric surgery. No outcome trial shows that a department using C-SATS trains surgeons faster or has fewer complications.

Who is C-SATS for?

A surgical residency director who wants objective, repeatable ratings of trainee video for milestone reviews is the intended buyer. So is a hospital quality lead in minimally invasive surgery who already records cases and wants structured feedback on them, and a department with a J&J MedTech relationship may find procurement simpler.

C-SATS does not suit a solo surgeon or small ambulatory center without a recording workflow, a team needing live intraoperative support, or anyone who must justify the purchase with outcome data. For credentialing and training feedback the method is defensible, and for a department with no recording infrastructure it is the wrong first purchase.

The verdict

C-SATS is a credible tool for scoring surgical video, with validation work behind the crowd-rating method and a large corporate owner. It is narrow, it depends on recording habits that many departments lack, and its effect on training outcomes is not shown. Before buying, ask for the HITRUST letter, the current product scope within J&J, and a list of customers you can call. On cost, no price is published as of October 2026 and the vendor sells on an enterprise basis.

Editorial review last generated October 14, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

Pricing

What it costs

Free tier only, no paid plans publicly disclosed.

TierMonthlyAnnualNotes
Plan——Enterprise.

Source: vendor pricing page. Last checked October 14, 2026.

Peer-reviewed coverage

What the literature says

3 peer-reviewed studies indexed on PubMed evaluate C-SATS in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Evaluating the evaluators: does C-SATS measure up?
Laverty RB, Chesnut CH, Karam JR, et al.· Surg Endosc· 2025Observational
Robotic-assisted surgery has increased in prevalence, particularly in general surgery. The number of cases required to achieve adequate proficiency in robotic surgery, however, and the training metrics that correlate best with proficiency remain unclear. We sought to better define proficiency-based benchmarks in robotic-assisted cholecystectomies (RAC) and inguinal hernia repairs (RIHR) using a commercial crowd source based on competency platform. Multi-institutional cohort study in which 48 surgeons (senior residents, fellows, and practicing physicians) submitted representative videos of the…
Barriers to the adoption of routine surgical video recording: a mixed-methods qualitative study of a real-world implementation of a video recording platform.
Lam K, Simister C, Yiu A, et al.· Surg Endosc· 2024
Routine surgical video recording has multiple benefits. Video acts as an objective record of the operative record, allows video-based coaching and is integral to the development of digital technologies. Despite these benefits, adoption is not widespread. To date, only questionnaire studies have explored this failure in adoption. This study aims to determine the barriers and provide recommendations for the implementation of routine surgical video recording. A pre- and post-pilot questionnaire surrounding a real-world implementation of a C-SATS, an educational recording and surgical analytics p…
Cloud Based AI-Driven Video Analytics (CAVs) in Laparoscopic Surgery: A Step Closer to a Virtual Portfolio.
Gendia A· Cureus· 2022
To outline the use of cloud-based artificial intelligence (AI)-driven video analytics (CAVs) in minimally invasive surgery and to propose their potential as a virtual portfolio for trainee and established surgeons.  Methods: An independent online demonstration was requested from three platforms, namely Theator (Palo Alto, California, USA), Touch Surgery™ (Medtronic, London, England, UK), and C-SATS® (Seattle, Washington, USA). The assessed domains were online and app-based accessibility, the ability for timely trainee feedback, and AI integration for operation-specific steps…

See all on PubMed